Professional Summary »
Specializing In »
Practice Locations »
Referring Physicians »
Specializing In
- Autism Spectrum Disorders
- Depression
- Eating and Feeding Disorders
- Huntington's Disease
- Obsessive-Compulsive and Related Disorders
- Sleep-Wake Disorders
- Tourette's Disorder
Biography
Dr. Kratter is an adult psychiatrist and fellowship-trained neuropsychiatrist and Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. He is also director of Invasive Technologies in the Stanford Brain Stimulation Laboratory.
His clinical interests include the psychiatric and cognitive aspects of movement disorders like Parkinson's and Tourette's as well as depression, obsessive-compulsive disorder, and non-invasive and invasive neuromodulation for neuropsychiatric illness.
His research interests focus on assessing outcomes and understanding the mechanisms of both neuromodulatory and novel pharmacological treatments. This includes both clinical and more mechanistic studies, such as using techniques like repetitive transcranial magnetic stimulation (rTMS) and deep brain stimulation in combination with neuroimaging and electrophysiology. He has been a co-investigator for such studies focusing on obsessive-compulsive disorder, major depressive disorder, and suicidal ideation, and traumatic brain injury.
His work has appeared in a number of scientific journals including Nature Medicine, American Journal of Psychiatry, Journal of Clinical Investigation, Translational Psychiatry, and Proceedings of the National Academy of Science. He also co-authored the chapter on major depression in the textbook Deep Brain Stimulation: Techniques and Practice.
His clinical interests include the psychiatric and cognitive aspects of movement disorders like Parkinson's and Tourette's as well as depression, obsessive-compulsive disorder, and non-invasive and invasive neuromodulation for neuropsychiatric illness.
His research interests focus on assessing outcomes and understanding the mechanisms of both neuromodulatory and novel pharmacological treatments. This includes both clinical and more mechanistic studies, such as using techniques like repetitive transcranial magnetic stimulation (rTMS) and deep brain stimulation in combination with neuroimaging and electrophysiology. He has been a co-investigator for such studies focusing on obsessive-compulsive disorder, major depressive disorder, and suicidal ideation, and traumatic brain injury.
His work has appeared in a number of scientific journals including Nature Medicine, American Journal of Psychiatry, Journal of Clinical Investigation, Translational Psychiatry, and Proceedings of the National Academy of Science. He also co-authored the chapter on major depression in the textbook Deep Brain Stimulation: Techniques and Practice.
View Full Biography »
Professional Summary
Education & Certifications
- Board Certification: American Osteopathic Board of Neurology and Psychiatry, Behavioral Neurology and Neuropsychiatry (2020)
- Board Certification, United Council for Neurologic Subspecialties, Behavioral Neurology and Neuropsychiatry (2020)
- Board Certification: American Board of Psychiatry and Neurology, Psychiatry (2019)
- Fellowship: Stanford University Psychiatry and Behavioral Sciences (2020) CA
- Residency: Western Psychiatric Institute and Clinic (2019) PA
- Medical Education: University of California San Francisco Registrar Office (2015) CA
Publications
-
Serine 421 regulates mutant huntingtin toxicity and clearance in mice
Kratter, I. H., Zahed, H., Lau, A., Tsvetkov, A. S., Daub, A. C., Weiberth, K. F., … Finkbeiner, S. (2016). Serine 421 regulates mutant huntingtin toxicity and clearance in mice. JOURNAL OF CLINICAL INVESTIGATION, 126(9), 3585–97. -
Sequence-Level Analysis of the Major European Huntington Disease Haplotype
Lee, J.-M., Kim, K.-H., Shin, A., Chao, M. J., Abu Elneel, K., Gillis, T., … Gusella, J. F. (2015). Sequence-Level Analysis of the Major European Huntington Disease Haplotype. AMERICAN JOURNAL OF HUMAN GENETICS, 97(3), 435–44. -
Targeting H3K4 trimethylation in Huntington disease
Vashishtha, M., Ng, C. W., Yildirim, F., Gipson, T. A., Kratter, I. H., Bodai, L., … Thompson, L. M. (2013). Targeting H3K4 trimethylation in Huntington disease. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(32), E3027–E3036. -
Stereoselective macrocyclization through zirconocene-mediated coupling of achiral dialkynes
Tannaci, J. F., Kratter, I. H., Rider, E. A., McBee, J. L., Miller, A. D., & Tilley, T. D. (2009). Stereoselective macrocyclization through zirconocene-mediated coupling of achiral dialkynes. CHEMICAL COMMUNICATIONS, (2), 233–34. -
DBS in major depression
Kratter, I. H., Richardson, R. M., & Karp, J. F. (2019). DBS in major depression. Deep Brain Stimulation: Techniques and Practice. Thieme Medical Publishers. -
Anterior Sensorimotor Subthalamic Nucleus Stimulation Is Associated With Improved Voice Function.
Jorge, A., Dastolfo-Hromack, C., Lipski, W. J., Kratter, I. H., Smith, L. J., Gartner-Schmidt, J. L., & Richardson, R. M. (2020). Anterior Sensorimotor Subthalamic Nucleus Stimulation Is Associated With Improved Voice Function. Neurosurgery. -
PolyQ Disease: Too Many Qs, Too Much Function?
Kratter, I. H., & Finkbeiner, S. (2010). PolyQ Disease: Too Many Qs, Too Much Function? NEURON, 67(6), 897–99. -
Association of Preoperative Visual Hallucinations With Cognitive Decline After Deep Brain Stimulation for Parkinson's Disease.
Kratter, I. H., Karp, J. F., Chang, Y.-F., Whiteman, A. C., Feyder, M. T., Jorge, A., … Henry, L. C. (2020). Association of Preoperative Visual Hallucinations With Cognitive Decline After Deep Brain Stimulation for Parkinson's Disease. The Journal of Neuropsychiatry and Clinical Neurosciences, appineuropsych20040077. -
Can (or Should) We Treat Depression and Anxiety in Parkinson's Disease Algorithmically?
Martyna, M. R., Trapp, N. T., & Kratter, I. H. (2021). Can (or Should) We Treat Depression and Anxiety in Parkinson's Disease Algorithmically? The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry. -
Lateralized Effect of Thalamic Deep Brain Stimulation Location on Verbal Abstraction.
Wang, D., Jorge, A., Lipski, W. J., Kratter, I. H., Henry, L. C., & Richardson, R. M. (2021). Lateralized Effect of Thalamic Deep Brain Stimulation Location on Verbal Abstraction. Movement Disorders : Official Journal of the Movement Disorder Society. -
Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for Parkinson's disease.
Kratter, I. H., Jorge, A., Feyder, M. T., Whiteman, A. C., Chang, Y.-F., Henry, L. C., … Richardson, R. M. (2022). Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for Parkinson's disease. Translational Psychiatry, 12(1), 213. -
Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression.
Mitra, A., Raichle, M. E., Geoly, A. D., Kratter, I. H., & Williams, N. R. (2023). Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression. Proceedings of the National Academy of Sciences of the United States of America, 120(21), e2218958120. -
Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial.
Batail, J.-M., Xiao, X., Azeez, A., Tischler, C., Kratter, I. H., Bishop, J. H., … Williams, N. R. (2023). Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial. Translational Psychiatry, 13(1), 240. -
Responsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsion.
Nho, Y.-H. H., Rolle, C. E., Topalovic, U., Shivacharan, R. S., Cunningham, T. N., Hiller, S., … Halpern, C. H. (2023). Responsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsion. Neuron. -
A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder.
Sahlem, G. L., Kim, B., Baker, N. L., Wong, B. L., Caruso, M. A., Campbell, L. A., … McRae-Clark, A. L. (2023). A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder. Drug and Alcohol Dependence, 254, 111035. -
Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment.
Geoly, A. D., Kratter, I. H., Toosi, P., Cole, E. J., Sahlem, G. L., & Williams, N. R. (2024). Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment. The American Journal of Psychiatry, 181(1), 71–73. -
Magnesium-ibogaine therapy in veterans with traumatic brain injuries.
Cherian, K. N., Keynan, J. N., Anker, L., Faerman, A., Brown, R. E., Shamma, A., … Williams, N. R. (2024). Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine. -
Pilot study of stanford neuromodulation therapy (SNT) for bipolar depression.
Raj, K. S., Geoly, A. D., Veerapal, C., Gholmieh, M., Toosi, P., Espil, F. M., … Williams, N. R. (2024). Pilot study of stanford neuromodulation therapy (SNT) for bipolar depression. Brain Stimulation.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder »
- Accelerated Theta Burst in Treatment-Resistant Depression: A Dose Finding and Biomarker Study »
- Neuroimaging Biomarkers for Predicting rTMS Response in OCD »
- Opiate Suicide Study in Patients With Major Depression »
Practice Locations
Outpatient Psychiatry Clinic in Palo Alto Stanford, CA
Stanford, CA
Outpatient Psychiatry Clinic in Palo Alto
401 Quarry Road
Stanford , CA 94304
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records